Stability-indicating RP-HPLC method for simultaneous determination of olmesartan medoxamil and pioglitazone in fixed dose combination tablet dosage form

Asian Journal of Chemistry

Volumn 22, Issue 8, 2010, Pages 6471-6479

  Sengupta, Pinaki ^a   Das, Ayan ^a   Pal, Tapan Kumar ^a  

^a JADAVPUR UNIVERSITY   (India)

Author keywords

HPLC; Olmesartan; Pioglitazone; Stability indicating method; Validation

Indexed keywords

EID: 77955860571     PISSN: 09707077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. A. Zanchetti and L.M. Ruilope, J. Hypertens., 20, 2099 (2002).
2. S.N. Arya, Indian J. Acad. Clin. Med., 4, 96 (2003).
3. A. Zanchi, A.G. Dulloo, C. Perregaux, J.P. Montani and M. Burnier, Am. J. Physiol. Endocrinol. Metab., 293, 91 (2007).
4. T. Nakamura, E. Yamamoto, K. Kataoka, T. Yamashita, Y. Tokutomi, Y.F. Dong, S. Matsuba, H. Ogawa and S. Kim-Mitsuyama, Hypertension, 51, 296 (2008).
5. S. Kim-Mitsuyama, E. Yamamoto, T. Tanaka, Y. Zhan, Y. Izumi, Y. Izumiya, T. Ioroi, H. Wanibuchi and H. Iwao, Stroke, 36, 1083 (2005).
6. T. Nakamura, E. Yamamoto, K. Kataoka, T. Yamashita, Y. Tokutomi, Y.F. Dong, S. Matsuba, H. Ogawa and S. Kim-Mitsuyama, Stroke, 38, 3016 (2007).
7. K.K. Koh and M.J. Quon, Hypertension, 52, 18 (2008).
8. H. Yanagisawa, Y. Amemiya, T. Kanazaki, Y. Shimoji, K. Fujimoto, Y. Kitahara, T. Sada, M. Mizuno, M. Ikeda, S. Miyamoto, Y. Furukawa and H. Koike, J. Med. Chem., 39, 323 (1996).
9. G. Orasanu, Z. Ouliana, P.R. Devchand, V. Nehra, O. Hamdy, E.S. Horton and J. Plutzky, Am. Coll. Cardiol., 52, 869 (2008).
10. A. Fahim, K.C.L. Nereida and M.R. Gerald, Metabolism, 58, 373 (2009).
11. Text on Validation of Analytical Procedures, International Conference on Harmonization, September (1993).
12. Proceedings of the International Conference on Harmonization of Technical Requirements of Registration of Pharmaceuticals for Human Use (ICH Harmonized Tripartite Guidelines), Validation of Analytical Procedures: Methodology, ICH-Q2B, Geneva (1996).
13. Q2 (R1) ICH guidelines, Validation of Analytical Procedures: Text and Methodology.
14. Proceedings of the International Conference on Harmonization of Technical Requirements of Registration of Pharmaceuticals for Human Use, Validation of Analytical Procedures, ICH-Q2A, Geneva (1995).
15. United States Pharmacopoeia 28, National Formulary 23, Validation of Compendial Methods, Rockville: U.S. Pharmacopoeial Convention Inc; 2748-2751, (General Chapter 1225) (2005).
16. S. Baboota, Acta Chromatogr., 18, 116 (2007).
17. F.A. Chaibva and R.B. Walker, J. Pharm. Biomed. Anal., 43, 179 (2007).
18. P. Trivedi, C. Kartikeyan, K. Raman and B. Rajendra, J. Liq. Chromatogr. Rel. Tech., 32, 1516 (2009).
19. V.P. Rane, K.R. Patil, J.N. Sangshetti, R.D. Yeole and D.B. Shinde, Chromatographia, 69, 169 (2009).
20. D.B. Wanjari and N.J. Gaikwad, Indian J. Pharm. Sci., 67, 256 (2005).